Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3

Richard B. Pollard; Dolores Peterson; David Hardy; John Pottage; Robert L. Murphy; Joseph Gathe; Gildon Beall; Victoria Rutkievicz; Laurie Reynolds; Anne P. Cross; Lisa M. Dunkle

doi:10.1097/00042560-199909010-00005

Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm³

Richard B. Pollard
, Dolores Peterson
, David Hardy
, John Pottage
, Robert L. Murphy
, Joseph Gathe
, Gildon Beall
, Victoria Rutkievicz
, Laurie Reynolds
, Anne P. Cross
, Lisa M. Dunkle

University of Texas Medical Branch at Galveston
University of Texas Southwestern Medical Center
University of California Los Angeles
Rush University Medical College
Northwestern University Feinberg School of Medicine
Park Plaza Medical Center
Harbor-UCLA Medical Center
Bristol-Myers Squibb

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	39-48
Number of pages	10
Journal	Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1097/00042560-199909010-00005
State	Published - Sep 1 1999
Externally published	Yes

ASJC Scopus Subject Areas

Immunology and Allergy
Immunology
Virology

Keywords

Antiretroviral therapy
Didanosine
Drug therapy, combination
Stavudine

Access to Document

10.1097/00042560-199909010-00005

Cite this

Pollard, R. B., Peterson, D., Hardy, D., Pottage, J., Murphy, R. L., Gathe, J., Beall, G., Rutkievicz, V., Reynolds, L., Cross, A. P., & Dunkle, L. M. (1999). Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm³. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 22(1), 39-48. https://doi.org/10.1097/00042560-199909010-00005

Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm³. / Pollard, Richard B.; Peterson, Dolores; Hardy, David et al.
In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 22, No. 1, 01.09.1999, p. 39-48.

Research output: Contribution to journal › Article › peer-review

Pollard, RB, Peterson, D, Hardy, D, Pottage, J, Murphy, RL, Gathe, J, Beall, G, Rutkievicz, V, Reynolds, L, Cross, AP & Dunkle, LM 1999, 'Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm³', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 22, no. 1, pp. 39-48. https://doi.org/10.1097/00042560-199909010-00005

@article{2048e1f564c148e8902217efe04e8e6f,

title = "Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3",

keywords = "Antiretroviral therapy, Didanosine, Drug therapy, combination, Stavudine",

author = "Pollard, \{Richard B.\} and Dolores Peterson and David Hardy and John Pottage and Murphy, \{Robert L.\} and Joseph Gathe and Gildon Beall and Victoria Rutkievicz and Laurie Reynolds and Cross, \{Anne P.\} and Dunkle, \{Lisa M.\}",

year = "1999",

month = sep,

day = "1",

doi = "10.1097/00042560-199909010-00005",

language = "English",

volume = "22",

pages = "39--48",

journal = "Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",

issn = "1077-9450",

publisher = "Lippincott, Williams \& Wilkins",

number = "1",

}

TY - JOUR

T1 - Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3

AU - Pollard, Richard B.

AU - Peterson, Dolores

AU - Hardy, David

AU - Pottage, John

AU - Murphy, Robert L.

AU - Gathe, Joseph

AU - Beall, Gildon

AU - Rutkievicz, Victoria

AU - Reynolds, Laurie

AU - Cross, Anne P.

AU - Dunkle, Lisa M.

PY - 1999/9/1

Y1 - 1999/9/1

KW - Antiretroviral therapy

KW - Didanosine

KW - Drug therapy, combination

KW - Stavudine

UR - https://www.scopus.com/pages/publications/0344980382

UR - https://www.scopus.com/pages/publications/0344980382#tab=citedBy

U2 - 10.1097/00042560-199909010-00005

DO - 10.1097/00042560-199909010-00005

M3 - Article

C2 - 10534145

AN - SCOPUS:0344980382

SN - 1077-9450

VL - 22

SP - 39

EP - 48

JO - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

JF - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

IS - 1